Skip to main content
OpenTrials

Clinical trial condition

Hypergammaglobulinemia

Explore clinical trials studying Hypergammaglobulinemia. Study availability and eligibility vary by location and protocol.

137 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Hypergammaglobulinemia trial results

Completed

Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma

NCT01222286

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mount Sinai School of Medicine New York, United States
  • Ohio State University Columbus, Ohio, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Imaging in MGUS, SMM and MM

NCT01237054

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients

NCT03792763

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin V Hämatologie und Onkologie Innsbruck, Austria
  • LKH Hochsteiermark, Standort Leoben, Abteilung für Innere Medizin und Hämatologie und internistische Onkologie Leoben, Austria
View Trial Details

Related conditions